OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Price, News & Analysis $1.62 -0.04 (-2.42%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$1.57▼$1.6550-Day Range$1.38▼$2.0052-Week Range$1.06▼$2.77Volume169,374 shsAverage Volume784,235 shsMarket Capitalization$788.35 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Cresco Labs alerts: Email Address Cresco Labs MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside54.8% Upside$2.50 Price TargetShort InterestHealthy0.38% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.05Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.13) to $0.05 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.89 out of 5 stars 3.5 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageCresco Labs has only been the subject of 3 research reports in the past 90 days.Read more about Cresco Labs' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.38% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 6.44%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRLBF. Previous Next 2.8 News and Social Media Coverage News SentimentCresco Labs has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cresco Labs this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for CRLBF on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is a decrease of -57% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.05% of the stock of Cresco Labs is held by institutions.Read more about Cresco Labs' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.13) to $0.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -3.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -3.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankGo here to get full details on this crypto now. About Cresco Labs Stock (OTCMKTS:CRLBF)Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More CRLBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRLBF Stock News HeadlinesSeptember 4 at 4:57 AM | americanbankingnews.comCresco Labs Inc. (OTCMKTS:CRLBF) Sees Significant Increase in Short InterestSeptember 4 at 3:49 AM | americanbankingnews.comCresco Labs Inc. (OTCMKTS:CRLBF) Given Average Recommendation of "Buy" by AnalystsSeptember 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 29, 2024 | seekingalpha.comCresco Labs Remains Strong Amidst Rescheduling Uncertainties (Hold)August 19, 2024 | nz.finance.yahoo.comCresco Labs Inc (6CQ.BE)August 14, 2024 | finance.yahoo.comNational Leading Vape Brand, Bloom, Partners With Cresco Labs to Launch Products in FloridaAugust 13, 2024 | proactiveinvestors.comCannabis MSOs embrace new markets, streamline operations in Q2August 13, 2024 | markets.businessinsider.comHaywood Reaffirms Their Buy Rating on Cresco Labs (CRLBF)September 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 8, 2024 | seekingalpha.comCresco Labs Inc. (CRLBF) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | finance.yahoo.comCresco Labs Reports Consistent Profitability Improvement with Second Quarter 2024 Financial ResultsAugust 8, 2024 | markets.businessinsider.comCresco Labs earnings: here's what to expectAugust 6, 2024 | finance.yahoo.comCresco Labs Launches Adult-Use Cannabis Distribution and Retail Sales in OhioJuly 30, 2024 | bizjournals.comCresco Labs in Yellow Springs receives dual use cannabis licenseJuly 25, 2024 | msn.comCresco Labs in Yellow Springs receives operational license for recreational weedJuly 9, 2024 | investorplace.com7 Pot Stock Pioneers Poised for High ReturnsMay 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cresco Labs (OtherCRLBF) and Immunocore Holdings (IMCR)May 16, 2024 | finance.yahoo.comCresco Labs Inc (CRLBF) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth Amidst ...See More Headlines Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees2,760Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$3.00 Low Stock Price Target$2.00 Potential Upside/Downside+54.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-175,520,000.00 Net Margins-23.07% Pretax Margin-17.58% Return on Equity-17.03% Return on Assets-5.13% Debt Debt-to-Equity Ratio1.76 Current Ratio2.00 Quick Ratio1.30 Sales & Book Value Annual Sales$770.89 million Price / Sales1.02 Cash Flow$0.05 per share Price / Cash Flow30.81 Book Value$0.77 per share Price / Book2.10Miscellaneous Outstanding Shares488,140,000Free FloatN/AMarket Cap$788.35 million OptionableNot Optionable Beta1.85 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Charles Bachtell (Age 45)Co-Founder, CEO & Director Comp: $999.85kMr. Robert M. Sampson (Age 49)Co-Founder & Independent Director Mr. Dennis M. Olis (Age 61)Chief Financial Officer Comp: $622.85kMr. Gregory Butler (Age 43)President & Chief Transformation Officer Mr. Ty Gent (Age 65)Chief Operating Officer Mr. Zach Marburger (Age 39)Chief Information Officer Ms. Megan KulickSenior Vice President of Investor RelationsMr. John Schetz (Age 46)General Counsel Mr. Jason Erkes (Age 53)Chief Communications Officer Ms. Angie Demchenko (Age 43)Chief People Officer More ExecutivesKey CompetitorsHUTCHMEDNASDAQ:HCMRhythm PharmaceuticalsNASDAQ:RYTMMoonLake ImmunotherapeuticsNASDAQ:MLTXMerusNASDAQ:MRUSXenon PharmaceuticalsNASDAQ:XENEView All Competitors CRLBF Stock Analysis - Frequently Asked Questions How have CRLBF shares performed this year? Cresco Labs' stock was trading at $1.3558 at the start of the year. Since then, CRLBF shares have increased by 19.1% and is now trading at $1.6150. View the best growth stocks for 2024 here. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings data on Thursday, August, 8th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.15. The firm had revenue of $184.36 million for the quarter, compared to the consensus estimate of $184.26 million. Cresco Labs had a negative net margin of 23.07% and a negative trailing twelve-month return on equity of 17.03%. How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRLBF) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cresco Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.